Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
24,661,077
-
Share change
-
-184,940
-
Total reported value
-
$3,377,943,330
-
Put/Call ratio
-
262%
-
Price per share
-
$136.93
-
Number of holders
-
292
-
Value change
-
-$25,150,866
-
Number of buys
-
144
-
Number of sells
-
124
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q4 2017
As of 31 Dec 2017,
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by
292 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,661,077 shares.
The largest 10 holders included
BlackRock Inc., Vanguard Group Inc, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, STATE STREET CORP, JANUS HENDERSON GROUP PLC, Knott David M, CARDINAL CAPITAL MANAGEMENT LLC /CT, VICTORY CAPITAL MANAGEMENT INC, Bank of New York Mellon Corp, and BANK OF AMERICA CORP /DE/.
This page lists
293
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.